Genmab A/S (NASDAQ:GMAB) Q2 2023 Earnings Call Transcript August 3, 2023
Genmab A/S misses on earnings expectations. Reported EPS is $0.3 EPS, expectations were $0.31.
Operator: Hello, and welcome to Genmab’s Second Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded. During this telephone conference, you may be presented with forward-looking statements that include words such as believes, anticipates, plans, or expects. Actual results may...
